A new UCLA Health study published in The Lancet Healthy Longevity reveals that older adults who undergo cognitive behavioral therapy for insomnia experience a significantly slower pace of biological aging and higher remission rates compared to those receiving standard sleep health education.
Between 10% and 25% of adults over the age of 65 in the United States struggle with clinical insomnia, a condition traditionally managed primarily as a quality-of-life issue. New clinical research indicates that addressing sleeplessness may actually alter how the body ages at a cellular level according to findings published by UCLA Health. By targeting the behaviors and thought patterns that sustain insomnia, clinical interventions can transform a chronic complaint into a modifiable health target.
Randomized Controlled Clinical Trial and Epigenetic Clock Analysis
To evaluate whether sleep treatment alters cellular aging, investigators conducted a randomized controlled trial involving nearly 100 older adults diagnosed with clinical insomnia. Participants were assigned either to structured cognitive behavioral therapy for insomnia or to a control group receiving standard sleep education therapy as detailed in the research data. While the informational sleep education program offered general advice on sleep hygiene without behavioral strategies, the clinical therapy delivered targeted sessions with trained clinicians.
Researchers collected blood samples before the eight-week intervention began and during follow-up visits spanning two years. By extracting DNA from these samples, the team tracked biological aging through three distinct epigenetic clocks: DunedinPACE, GrimAge, and PC-PhenoAge. Prior scientific literature has established a clear link between clinical sleep disruption and advanced biological aging, which is tracked through alterations in DNA methylation—the cellular mechanism that turns specific genes on or off as outlined in the trial results. This cellular acceleration subsequently increases the long-term risk of mortality, cardiovascular disease, and diabetes.
Remission Rates and Slower Biological Aging Metrics
The trial demonstrated clear divergence between the treatment groups over the observation period. Patients who completed the behavioral therapy achieved a nearly threefold greater likelihood of insomnia remission than individuals in the education-only control group. Furthermore, epigenetic analysis revealed that the therapy significantly slowed the pace of aging as measured specifically by the DunedinPACE clock.
“Insomnia in older adults is often treated as a quality-of-life issue, but these findings suggest it may also be a modifiable risk factor for how the body ages.”
Dr Judith Carroll, associate professor of psychiatry at UCLA Health and lead author of the study
The study authors emphasize that sleep should be viewed with the same clinical gravity as established lifestyle interventions. Just as we counsel patients on physical activity and diet to support healthy aging, this points to sleep as another important behavior worth targeting to improve health,
Dr. Carroll noted in a news release accompanying the publication.
Broader Temporal Systems Biology and Future Study Directions
The connection between rest and temporal biology extends beyond localized neural function. Large-scale investigations into multi-organ aging clocks, such as work conducted across extensive population cohorts, indicate that deviations from optimal sleep duration register across numerous physiological systems, including the heart, lungs, liver, immune system, and pancreas according to a study published in Nature. Short sleep patterns under six hours and long sleep patterns exceeding eight hours both correlate with elevated systemic disease risks and all-cause mortality, operating through distinct pathways involving acute stress, metabolic disruption, and inflammatory signaling.
Despite these promising insights, the UCLA Health research team notes important limitations in their trial design. All participants were recruited from a single healthcare site located in Los Angeles, California. Investigators acknowledge that larger, multisite trials featuring more diverse cohorts across different races, ethnicities, and age brackets will be required to confirm whether these epigenetic benefits apply broadly. Additional research is also required to establish whether treatment responses differ significantly between sexes or if alternative interventions—such as pharmacotherapy or Tai Chi—produce comparable effects on the human biological clock.
Читайте также
